We found that RUNX1 highly expressed glioma had lower overall survival than RUNX1 lowly expressed glioma patients in TCGA (P < 0.0001) and CGGA (P < 0.0001) datasets (Fig. 4h). The gene discussed is RUNX1; the disease is central nervous system cancer.